NPI registry status
Active
2026 NPPES data Oncology Pharmacist NPI 1528761806 PHARMD
Verify on CMS → Rabeya Molla, PHARMD
Oncology Pharmacist in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,720 in Oncology Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
47
Medicare Part D claims · 19 beneficiaries · Oncology Pharmacist avg: 160
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Rabeya Molla, PHARMD filed 47 Medicare Part D claims in 2023 as a Oncology Pharmacist in New York, New York.
- 47
- Part D claims, 2023
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rabeya Molla, PHARMD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
47 0th percentile higher than 0% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Rabeya Molla, PHARMD?
Quality data not reportedPrimary specialty
Oncology Pharmacist
Medicare Part D claims
47 71% vs specialty avg
Specialty distribution in New York
How Oncology Pharmacist compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oncology Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rabeya Molla, PHARMD appears in the CMS NPPES registry as an Oncology Pharmacist provider holding PHARMD credentials at 1275 YORK AVE, New York, NY, 10065, with a listed phone of (646) 545-1561. NPI 1528761806 was issued on 03/24/2023.
Medicare Part D records for calendar year 2023 show 47 prescription claims written by this provider, covering 19 Medicare beneficiaries and totaling roughly $3K in drug spend.
Oncology Pharmacist is a narrow specialty nationwide, with 1,720 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1528761806 |
|---|---|
| Specialty | Oncology Pharmacist |
| Credentials | PHARMD |
| Gender | Female |
| NPI Issued | 03/24/2023 |
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Rabeya Molla, PHARMD. To verify Rabeya Molla, PHARMD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
47
Total Claims
$3K
Total Drug Cost
19
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 47
- Total Day Supply
- 1,052
- Generic Drug Cost
- $2K
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 2.08
Oncology Pharmacist Overview
How Rabeya Molla, PHARMD fits within the Oncology Pharmacist landscape nationally.
1,720
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider
Rabeya Molla, PHARMD's 47 claims are below the specialty average of 160.
Nearby Oncology Pharmacist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Molla.
Dr. Nouran Aboelregal
PHARMD
New York, NY
Rachel Abramova
New York, NY
Dr. Jonathan Adams
PHARM.D.
Buffalo, NY
Salma Afifi
New York, NY
Dr. Troy Agard
PHARMD
Great Neck, NY
Compare Oncology Pharmacist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Oncology Pharmacist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Rabeya Molla, PHARMD's specialty? ▼
Rabeya Molla, PHARMD specializes in Oncology Pharmacist and practices in New York, New York. Credentials: PHARMD.
How much does Rabeya Molla, PHARMD prescribe under Medicare Part D? ▼
In 2023, Rabeya Molla, PHARMD wrote 47 Medicare Part D claims totaling $3K in drug costs for 19 beneficiaries.
Where is Rabeya Molla, PHARMD located? ▼
Rabeya Molla, PHARMD is located at 1275 YORK AVE, New York, NY, 10065. Phone: (646) 545-1561.
What is Rabeya Molla, PHARMD's NPI number? ▼
Rabeya Molla, PHARMD's National Provider Identifier (NPI) is 1528761806, issued on 03/24/2023.
How many Oncology Pharmacist providers are there in the US? ▼
There are 1,720 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does Rabeya Molla, PHARMD accept Medicare? ▼
Rabeya Molla, PHARMD appears in CMS Medicare data with 47 Part D claims and 19 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rabeya Molla, PHARMD's credentials? ▼
Rabeya Molla, PHARMD's NPI is 1528761806 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.